Provid Pharmaceuticals Inc.
Records under this name other than the patents Provid Pharmaceuticals Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 2 patents it holds.
Back to Provid Pharmaceuticals Inc.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 9,376,437 | 7-benzyl-4-(2-methylbenzyl)-2,4,6,7,8,9-hexahydroimidazo[1,2-a]pyrido[3,4-e]pyrimidin-5(1H)-one, salts thereof and methods of using the same in combination therapy Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 9,688,679 | 7-Benzyl-4-(methylbenzyl)-2,4,6,7,8,9-hexahydroimidazo[1,2-a]pyrido[3,4-e]pyrimidin-5 (1H)-One, Salts Thereof and Methods of Using the Same in Combination Therapy Formerly held In force · Medium confidence | In force | Medium confidence | |
| US 9,265,765 | 7-Benzyl-10-(2-methylbenzyl)-2,6,7,8,9,10-hexahydroimidazo[1,2-a]pyrido[4,3-d]pyrimidin-5(3h)-one, Salts Thereof and Methods of Using the Same in Combination Therapy Formerly held In force · High confidence | In force | High confidence | |
| US 9,845,324 | 7-Benzyl-4-(2-Methylbenzyl)-2,4,6,7,8,9-Hexahydroimidazo [1,2-a]pyrido[3,4-e]pyrimidin-5(1h)-one, Analogs Thereof, and Salts Thereof and Methods for Their Use in Therapy Formerly held In force · High confidence | In force | High confidence | |
| US 10,266,533 | 7-Benzyl-4-(2-Methylbenzyl)-2,4,6,7,8,9-Hexahydroimidazo [1,2-a]pyrido[3,4-e]pyrimidin-5(1h)-one, Analogs Thereof, and Salts Thereof and Methods for Their Use in Therapy Formerly held In force · Medium confidence | In force | Medium confidence | |
| US 11,976,068 | 7-Benzyl-4-(2-Methylbenzyl)-2,4,6,7,8,9-Hexahydroimidazo [1,2-a]PYRIDO[3,4-e]PYRIMIDIN-5(1H)-ONE, ANALOGS THEREOF, AND SALTS THEREOF AND METHODS FOR THEIR USE IN THERAPY Formerly held In force · Medium confidence | In force | Medium confidence | |
| US 7,439,231 | Inhibitors of antigen presentation by MHC class II molecules and methods of use thereof Term ended Term ended Sep 29, 2025 · From the USPTO record | Term ended | Term ended Sep 29, 2025 | From the USPTO record |
| US 7,432,342 | Kinase Anchor Protein Muteins, Peptides Thereof, and Related Methods Formerly held Term ended Term ended Sep 16, 2024 · High confidence | Term ended | Term ended Sep 16, 2024 | High confidence |
| US 8,222,215 | Methods for the use of inhibitors of antigen presentation by MHC class II molecules Lapsed on the fee record Ended Jul 17, 2024 · From the USPTO record | Lapsed on the fee record | Ended Jul 17, 2024 | From the USPTO record |
| US 7,947,645 | APO E analogs and methods for their use Formerly held Lapsed on the fee record Ended May 24, 2023 · From the USPTO record | Lapsed on the fee record | Ended May 24, 2023 | From the USPTO record |